Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?
Cancer J. 2011 Sep-Oct;17(5):343-50. doi: 10.1097/PPO.0b013e318233e5b2.
Cancer J. 2011.
PMID: 21952285
Free PMC article.
Review.
Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies.
Chianese-Bullock KA, Lewis ST, Sherman NE, Shannon JD, Slingluff CL Jr.
Chianese-Bullock KA, et al.
Vaccine. 2009 Mar 10;27(11):1764-70. doi: 10.1016/j.vaccine.2009.01.018. Epub 2009 Feb 8.
Vaccine. 2009.
PMID: 19185050
Free PMC article.
Item in Clipboard
Cite
Cite